Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
20.0%
% of BBH's 27 holdings also in HRTS
12.8%
% of HRTS's 39 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 11.2% | 5.7% | 5.7% |
|
AMGEN INC | 16.6% | 5.1% | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% | 4.7% | 3.3% |
|
REGENERON PHARMACEUTICALS | 6.9% | 2.4% | 2.4% |
|
CYTOKINETICS INC | 0.9% | 3.3% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to HRTS
|
AMGEN INC | 11.5% |
|
GILEAD SCIENCES INC | 10.9% |
|
VERTEX PHARMACEUTICALS INC | 5.5% |
 |
ARGENX SE ADR | 5.4% |
|
IQVIA HOLDINGS INC | 4.6% |
|
REGENERON PHARMACEUTICALS | 4.5% |
|
ILLUMINA INC | 4.3% |
|
BIOGEN IDEC INC | 3.9% |
|
NATERA INC | 3.6% |
 |
ICON PLC | 3.3% |
BBH Underweight Relative to HRTS
|
ELI LILLY & CO | -6.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
 |
NOVO NORDISK A/S-B | -3.6% |
 |
ASTRAZENECA PLC | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.1% |
|
ASCENDIS PHARMA A/S | -3.1% |
|
MEDTRONIC PLC | -3.0% |
|
DEXCOM INC | -2.7% |